Our CEO, Dr. Tuvik Beker, will be presenting Pangea’s posters at the AACR Annual Meeting in Chicago this month.  Poster presentation details are as follows:

Title: Applying novel transcriptomics-based markers to predict response to durvalumab and olaparib in mTNBC from histopathological slidesSession Category: Clinical Research
Session Title: Predictive Biomarkers 2
Date/Time: April 27, 2025, 2:00pm – 5:00pm CT
Location: Poster Section 31
Poster Board Number: 14
Abstract Number: 729

Title: Can we overcome the scarcity of data for building predictive models in cancer?
Session Title: Predictive Biomarkers 2
Date/Time: April 27, 2025, 2:00pm – 5:00pm CT
Location: Poster Section 31
Poster Board Number: 15
Abstract Number: 730